Literature DB >> 12052963

Activation of endothelial cell protease activated receptor 1 by the protein C pathway.

Matthias Riewald1, Ramona J Petrovan, Aaron Donner, Barbara M Mueller, Wolfram Ruf.   

Abstract

The coagulant and inflammatory exacerbation in sepsis is counterbalanced by the protective protein C (PC) pathway. Activated PC (APC) was shown to use the endothelial cell PC receptor (EPCR) as a coreceptor for cleavage of protease activated receptor 1 (PAR1) on endothelial cells. Gene profiling demonstrated that PAR1 signaling could account for all APC-induced protective genes, including the immunomodulatory monocyte chemoattractant protein-1 (MCP-1), which was selectively induced by activation of PAR1, but not PAR2. Thus, the prototypical thrombin receptor is the target for EPCR-dependent APC signaling, suggesting a role for this receptor cascade in protection from sepsis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052963     DOI: 10.1126/science.1071699

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  287 in total

1.  The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b.

Authors:  Chunzhang Cao; Yamei Gao; Yang Li; Toni M Antalis; Francis J Castellino; Li Zhang
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

Review 2.  PARticipation in inflammation.

Authors:  Shaun R Coughlin; Eric Camerer
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 3.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

4.  β-Arrestin and dishevelled coordinate biased signaling.

Authors:  Gunnar Schulte; Sudha K Shenoy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

5.  Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models.

Authors:  J-S Bae; W Lee; A R Rezaie
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

Review 6.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

Review 7.  Signal transduction by protease-activated receptors.

Authors:  Unice J K Soh; Michael R Dores; Buxin Chen; JoAnn Trejo
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

8.  Protein C receptor stimulates multiple signaling pathways in breast cancer cells.

Authors:  Daisong Wang; Chunye Liu; Jingqiang Wang; Yingying Jia; Xin Hu; Hai Jiang; Zhi-Ming Shao; Yi Arial Zeng
Journal:  J Biol Chem       Date:  2017-12-07       Impact factor: 5.157

Review 9.  Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.

Authors:  Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2013-11-12       Impact factor: 2.490

Review 10.  2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: Thrombotic Stroke: Neuroprotective Therapy by Recombinant-Activated Protein C.

Authors:  John H Griffin; Laurent O Mosnier; José A Fernández; Berislav V Zlokovic
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10-06       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.